$13.94
0.50% yesterday
NYSE, May 20, 10:10 pm CET
ISIN
US58470H1014
Symbol
MED

Medifast Inc Stock price

$13.94
+1.94 16.17% 1M
-4.22 23.24% 6M
-3.68 20.89% YTD
-10.49 42.94% 1Y
-148.85 91.44% 3Y
-80.12 85.18% 5Y
-19.40 58.19% 10Y
NYSE, Closing price Tue, May 20 2025
-0.07 0.50%
ISIN
US58470H1014
Symbol
MED

Key metrics

Market capitalization $153.21m
Enterprise Value $3.23m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.24
EV/Sales (TTM) EV/Sales 0.01
P/S ratio (TTM) P/S ratio 0.28
P/B ratio (TTM) P/B ratio 0.73
Revenue growth (TTM) Revenue growth -39.47%
Revenue (TTM) Revenue $543.45m
EBIT (operating result TTM) EBIT $-6.32m
Free Cash Flow (TTM) Free Cash Flow $13.47m
Cash position $164.59m
EPS (TTM) EPS $-0.64
P/E forward negative
P/S forward 0.39
EV/Sales forward 0.01
Short interest 10.80%
Show more

Is Medifast Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Medifast Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Medifast Inc:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Medifast Inc:

Hold
100%

Financial data from Medifast Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
543 543
39% 39%
100%
- Direct Costs 142 142
41% 41%
26%
402 402
39% 39%
74%
- Selling and Administrative Expenses 386 386
30% 30%
71%
- Research and Development Expense 4.50 4.50
2% 2%
1%
11 11
89% 89%
2%
- Depreciation and Amortization 17 17
2% 2%
3%
EBIT (Operating Income) EBIT -6.32 -6.32
108% 108%
-1%
Net Profit -7 -7
110% 110%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Medifast Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medifast Inc Stock News

Neutral
Seeking Alpha
22 days ago
Medifast, Inc. (NYSE:MED ) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and CEO Jim Maloney - Chief Financial Officer Nick Johnson - Chief Field Operations Officer Conference Call Participants Jim Salera - Stephens Doug Lane - Water Tower Research Operator Greetings. And welcome to the Med...
Neutral
Business Wire
22 days ago
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, wh...
Negative
Seeking Alpha
about 2 months ago
Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as a GLP-1 adjacent business, but the repositioning hasn't shown results so far with a deteriorating immediate earnings outlook. MED stock now trades below the company's net cash position, but due to ...
More Medifast Inc News

Company Profile

Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD

Head office United States
CEO Daniel Chard
Employees 504
Founded 1981
Website www.medifastinc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today